Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 327,556 | 186,250 | 98,874 | 750,269 | 279,862 |
| Depreciation Amortization | 29,912 | 19,109 | 9,407 | 36,940 | 27,162 |
| Income taxes - deferred | 82,890 | 92,522 | 39,525 | -340,156 | 0 |
| Accounts receivable | -350,809 | -206,149 | -117,782 | -588,398 | -498,236 |
| Other Working Capital | -309,734 | -210,580 | -127,543 | -672,799 | -568,854 |
| Other Operating Activity | 527,052 | 333,260 | 183,767 | 739,529 | 592,266 |
| Operating Cash Flow | $306,867 | $214,412 | $86,248 | $-74,615 | $-167,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -158,160 | 24,601 | -126,482 | -31,736 | -138,001 |
| PPE Investments | -87,347 | -55,656 | -21,203 | -49,337 | -34,175 |
| Investing Cash Flow | $-245,507 | $-31,055 | $-147,685 | $-81,073 | $-172,176 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,625 | -997 | -649 | -2,203 | -1,601 |
| Common Stock Issued | 41,718 | 34,300 | 12,964 | 63,549 | 48,440 |
| Common Stock Repurchased | -166,358 | -73,137 | -3,085 | -163,300 | -71,475 |
| Other Financing Activity | 97,840 | 7,876 | 2,293 | 4,308 | 0 |
| Financing Cash Flow | $-28,425 | $-31,958 | $11,523 | $-97,646 | $-24,636 |
| Beginning Cash Position | 230,276 | 230,276 | 230,276 | 483,610 | 483,610 |
| End Cash Position | 263,211 | 381,675 | 180,362 | 230,276 | 118,998 |
| Net Cash Flow | $32,935 | $151,399 | $-49,914 | $-253,334 | $-364,612 |
| Free Cash Flow | |||||
| Operating Cash Flow | 306,867 | 214,412 | 86,248 | -74,615 | -167,800 |
| Capital Expenditure | -87,347 | -55,656 | -21,203 | -49,337 | -34,175 |
| Free Cash Flow | 219,520 | 158,756 | 65,045 | -123,952 | -201,975 |